• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝糖原贮积病:发病机制、临床症状及治疗管理

Hepatic glycogen storage diseases: pathogenesis, clinical symptoms and therapeutic management.

作者信息

Szymańska Edyta, Jóźwiak-Dzięcielewska Dominika A, Gronek Joanna, Niewczas Marta, Czarny Wojciech, Rokicki Dariusz, Gronek Piotr

机构信息

Department of Gastroenterology, Hepatology, Feeding Disorders and Pediatrics, The Children's Memorial Health Institute, Warsaw, Poland.

Laboratory of Genetics, Department of Gymnastics and Dance, University School of Physical Education, Poznan, Poland.

出版信息

Arch Med Sci. 2019 Feb 18;17(2):304-313. doi: 10.5114/aoms.2019.83063. eCollection 2021.

DOI:10.5114/aoms.2019.83063
PMID:33747265
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7959092/
Abstract

Glycogen storage diseases (GSDs) are genetically determined metabolic diseases that cause disorders of glycogen metabolism in the body. Due to the enzymatic defect at some stage of glycogenolysis/glycogenesis, excess glycogen or its pathologic forms are stored in the body tissues. The first symptoms of the disease usually appear during the first months of life and are thus the domain of pediatricians. Due to the fairly wide access of the authors to unpublished materials and research, as well as direct contact with the GSD patients, the article addresses the problem of actual diagnostic procedures for patients with the suspected diseases. Knowledge and awareness of the problem among physicians seem insufficient, and research on the diagnosis and treatment of GSD is still ongoing, resulting in a heterogeneous GSD typology and a changing way of its diagnosis and treatment.

摘要

糖原贮积病(GSDs)是由基因决定的代谢性疾病,可导致体内糖原代谢紊乱。由于糖原分解/糖原合成某些阶段的酶缺陷,过量的糖原或其病理形式会储存在身体组织中。该疾病的最初症状通常在出生后的头几个月出现,因此属于儿科医生的诊疗范围。鉴于作者能够相当广泛地获取未发表的材料和研究成果,以及与糖原贮积病患者的直接接触,本文探讨了疑似该病患者实际诊断程序的问题。医生们对该问题的了解和认识似乎不足,而且关于糖原贮积病诊断和治疗的研究仍在进行中,这导致了糖原贮积病类型的异质性以及其诊断和治疗方式的不断变化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c907/7959092/35383b326d9d/AMS-17-2-81093-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c907/7959092/9916c449c2ae/AMS-17-2-81093-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c907/7959092/35383b326d9d/AMS-17-2-81093-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c907/7959092/9916c449c2ae/AMS-17-2-81093-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c907/7959092/35383b326d9d/AMS-17-2-81093-g002.jpg

相似文献

1
Hepatic glycogen storage diseases: pathogenesis, clinical symptoms and therapeutic management.肝糖原贮积病:发病机制、临床症状及治疗管理
Arch Med Sci. 2019 Feb 18;17(2):304-313. doi: 10.5114/aoms.2019.83063. eCollection 2021.
2
Diagnosis and management of glycogen storage diseases type VI and IX: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG).糖原贮积病 VI 型和 IX 型的诊断与管理:美国医学遗传学与基因组学学会(ACMG)临床实践资源
Genet Med. 2019 Apr;21(4):772-789. doi: 10.1038/s41436-018-0364-2. Epub 2019 Jan 19.
3
Glycogen storage diseases: An update.糖原贮积病:更新。
World J Gastroenterol. 2023 Jul 7;29(25):3932-3963. doi: 10.3748/wjg.v29.i25.3932.
4
Glycogen metabolism and glycogen storage disorders.糖原代谢与糖原贮积症
Ann Transl Med. 2018 Dec;6(24):474. doi: 10.21037/atm.2018.10.59.
5
Glycogen storage diseases with liver involvement: a literature review of GSD type 0, IV, VI, IX and XI.伴有肝脏受累的糖原贮积病:GSD 类型 0、IV、VI、IX 和 XI 的文献复习。
Orphanet J Rare Dis. 2022 Jun 20;17(1):241. doi: 10.1186/s13023-022-02387-6.
6
Endocrine involvement in hepatic glycogen storage diseases: pathophysiology and implications for care.内分泌系统在肝糖原贮积病中的作用:病理生理学及对治疗的意义
Rev Endocr Metab Disord. 2024 Aug;25(4):707-725. doi: 10.1007/s11154-024-09880-2. Epub 2024 Apr 1.
7
Nutrition therapy for hepatic glycogen storage diseases.肝糖原贮积病的营养治疗
J Am Diet Assoc. 1993 Dec;93(12):1423-30. doi: 10.1016/0002-8223(93)92246-t.
8
Diagnosis of hepatic glycogen storage disease patients with overlapping clinical symptoms by massively parallel sequencing: a systematic review of literature.采用大规模平行测序对具有重叠临床症状的肝糖原贮积症患者进行诊断:文献系统评价。
Orphanet J Rare Dis. 2020 Oct 14;15(1):286. doi: 10.1186/s13023-020-01573-8.
9
Beyond predicting diagnosis: Is there a role for measuring biotinidase activity in liver glycogen storage diseases?超越诊断预测:测量生物素酶活性在肝糖原贮积病中是否有作用?
Mol Genet Metab Rep. 2022 Feb 28;31:100856. doi: 10.1016/j.ymgmr.2022.100856. eCollection 2022 Jun.
10
Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genomics.I型糖原贮积病的诊断与管理:美国医学遗传学与基因组学学会实践指南
Genet Med. 2014 Nov;16(11):e1. doi: 10.1038/gim.2014.128.

引用本文的文献

1
Clinical and molecular characterization of hepatic glycogen storage disease in Saudi Arabia.沙特阿拉伯肝糖原贮积病的临床与分子特征
PLoS One. 2025 Jul 31;20(7):e0329008. doi: 10.1371/journal.pone.0329008. eCollection 2025.
2
Efficacy of magnetic resonance imaging in managing glycogen storage disease.磁共振成像在糖原贮积病管理中的疗效
Orphanet J Rare Dis. 2025 Mar 27;20(1):144. doi: 10.1186/s13023-025-03605-7.
3
Comparison Between the Impact of Diabetes Mellitus on Liver Diseases and Vice Versa Among Saudi and Egyptian Patients.

本文引用的文献

1
MicroRNAs and metabolic disorders - where are we heading?微小RNA与代谢紊乱——我们正走向何方?
Arch Med Sci. 2017 Jun;13(4):885-896. doi: 10.5114/aoms.2017.65229. Epub 2017 Jan 19.
2
Evolutionary history of glucose-6-phosphatase encoding genes in vertebrate lineages: towards a better understanding of the functions of multiple duplicates.脊椎动物谱系中葡萄糖-6-磷酸酶编码基因的进化史:旨在更好地理解多个重复基因的功能
BMC Genomics. 2017 May 2;18(1):342. doi: 10.1186/s12864-017-3727-1.
3
CREBH Maintains Circadian Glucose Homeostasis by Regulating Hepatic Glycogenolysis and Gluconeogenesis.
沙特和埃及患者中糖尿病对肝脏疾病的影响及反之影响的比较
Healthcare (Basel). 2025 Feb 10;13(4):376. doi: 10.3390/healthcare13040376.
4
Liver at crossroads: unraveling the links between obesity, chronic liver diseases, and the mysterious obesity paradox.肝脏的十字路口:揭示肥胖、慢性肝病与神秘的肥胖悖论之间的联系。
Clin Exp Med. 2024 Oct 14;24(1):240. doi: 10.1007/s10238-024-01493-y.
5
A Functional Human Glycogen Debranching Enzyme Encoded by a Synthetic Gene: Its Implications for Glycogen Storage Disease Type III Management.一种功能性的人类糖原分支酶,由合成基因编码:对糖原贮积症 III 型治疗的启示。
Protein Pept Lett. 2024;31(7):519-531. doi: 10.2174/0109298665307430240628063339.
6
A case study of a liver transplant-treated patient with glycogen storage disease type Ia presenting with multiple inflammatory hepatic adenomas: an analysis of clinicopathologic and genetic data.糖原贮积病 Ia 型肝移植治疗患者伴多发性炎症性肝腺瘤病例研究:临床病理和遗传学数据分析。
BMC Med Genomics. 2024 May 6;17(1):124. doi: 10.1186/s12920-024-01888-6.
7
Genetics of enzymatic dysfunctions in metabolic disorders and cancer.代谢紊乱和癌症中酶功能障碍的遗传学
Front Oncol. 2023 Aug 2;13:1230934. doi: 10.3389/fonc.2023.1230934. eCollection 2023.
8
A patient with glycogen storage disease type IA combined with hepatic adenoma: A case report.1A型糖原贮积病合并肝腺瘤1例报告
Genes Dis. 2022 Aug 22;10(3):701-704. doi: 10.1016/j.gendis.2022.08.002. eCollection 2023 May.
9
Platelet glycogenolysis is important for energy production and function.血小板糖原分解对于能量产生和功能很重要。
Platelets. 2023 Dec;34(1):2222184. doi: 10.1080/09537104.2023.2222184.
10
The impact of postoperative blood glucose levels on complications and prognosis after esophagectomy in patients with esophageal cancer.食管癌患者术后血糖水平对并发症和预后的影响。
Surg Today. 2023 Aug;53(8):907-916. doi: 10.1007/s00595-023-02641-9. Epub 2023 Jan 20.
CREBH通过调节肝糖原分解和糖异生来维持昼夜节律性葡萄糖稳态。
Mol Cell Biol. 2017 Jun 29;37(14). doi: 10.1128/MCB.00048-17. Print 2017 Jul 15.
4
PHKA2 mutation spectrum in Korean patients with glycogen storage disease type IX: prevalence of deletion mutations.韩国IX型糖原贮积病患者的PHKA2突变谱:缺失突变的发生率
BMC Med Genet. 2016 Apr 21;17:33. doi: 10.1186/s12881-016-0295-1.
5
Crystal structure of glycogen debranching enzyme and insights into its catalysis and disease-causing mutations.糖原脱支酶的晶体结构及其催化作用和致病突变的见解
Nat Commun. 2016 Apr 18;7:11229. doi: 10.1038/ncomms11229.
6
Esophageal Stricture Secondary to Candidiasis in a Child with Glycogen Storage Disease 1b.1b型糖原贮积病患儿继发念珠菌病所致食管狭窄
Pediatr Gastroenterol Hepatol Nutr. 2016 Mar;19(1):71-5. doi: 10.5223/pghn.2016.19.1.71. Epub 2016 Mar 22.
7
Embryonal Hepatoblastoma with Co-existent Glycogen Storage Disease in a Seven-month-old Child.一名七个月大儿童患胚胎性肝母细胞瘤并伴有糖原贮积病
J Clin Diagn Res. 2016 Feb;10(2):ED09-10. doi: 10.7860/JCDR/2016/15984.7239. Epub 2016 Feb 1.
8
Spectrum of AGL mutations in Chinese patients with glycogen storage disease type III: identification of 31 novel mutations.中国III型糖原贮积病患者中AGL突变谱:31种新突变的鉴定
J Hum Genet. 2016 Jul;61(7):641-5. doi: 10.1038/jhg.2016.24. Epub 2016 Mar 17.
9
Measurements of Gluconeogenesis and Glycogenolysis: A Methodological Review.糖异生和糖原分解的测量:方法学综述
Diabetes. 2015 Dec;64(12):3996-4010. doi: 10.2337/db15-0640.
10
Alternative nighttime nutrition regimens in glycogen storage disease type I: a controlled crossover study.糖原贮积病I型的替代夜间营养方案:一项对照交叉研究。
J Inherit Metab Dis. 2015 Nov;38(6):1093-8. doi: 10.1007/s10545-015-9864-2. Epub 2015 Jun 25.